Serotonin and Mental Disorders: A Concise Review on Molecular Neuroimaging Evidence

키워드

참고문헌 (63)

1. Stanley M, "Increased serotonin-2 binding sites in frontal cortex of suicide victims", Lancet, 1, pp.214~216 (1983)
2. Berger M, "The expanded biology of serotonin", Annu Rev Med, 60, pp.355~366 (2009)
3. Paterson LM, "5-HT radioligands for human brain imaging with PET and SPECT", Med Res Rev, 33, pp.54~111 (2013)
4. Zipursky RB, "PET and SPECT imaging in psychiatric disorders", Can J Psychiatry, 52, pp.146~157 (2007)
5. Nikolaus S, "Key players in major and bipolar depression--a retrospective analysis of in vivo imaging studies", Behav Brain Res, 232, pp.358~390 (2012)
6. Drevets WC, "PET imaging of serotonin 1A receptor binding in depression", Biol Psychiatry, 46, pp.1375~1387 (1999)
7. WAY-100635: effects of depression and antidepressant treatment, "Arch Gen Psychiatry", 2000, 174~180
8. WAY-100635, "Int J Neuropsychopharmacol", 2008, 465~476
9. WAY-100635, "Mol Psychiatry", 2004, 386~392
10. WAY100635 positron emission tomography study, "Biol Psychiatry", 2006, 106~113
11. -2beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography, "Biol Psychiatry", 1998, 1090~1098
12. Newberg AB, "123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study", J Nucl Med, 46, pp.973~977 (2005)
13. nor-beta-CIT SPECT imaging, "Psychiatry Res", 2007, 125~131
14. Ahonen A, "Serotonin transporter availability in drug free depression patients using a novel SERT ligand", Eur J Nucl Med Mol Imaging, 31, pp.S227~S228 (2004)
15. Catafau AM, "Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study", Psychopharmacology (Berl), 189, pp.145~153 (2006)
16. -ADAM, "J Neural Transm", 2006, 659~670
17. Hsieh PC, "Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study", Psychiatry Res, 184, pp.157~161 (2010)
18. Hsieh PC, "Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder - a preliminary two-ligand SPECT study", Eur Psychiatry, (13), pp.S0924~S9338 (2014)
19. Parsey RV, "Lower serotonin transporter binding potential in the human brain during major depressive episodes", Am J Psychiatry, 163, pp.52~58 (2006)
20. (+)McN5652 shows increased serotonin transporter availability in major depression, "J Affect Disord", 2004, 321~327
21. Meyer JH, "Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes", Arch Gen Psychiatry, 61, pp.1271~1279 (2004)
22. DASB; comparison with bipolar disorder, "Biol Psychiatry", 2007, 62~870
23. Meyer JH., "Imaging the serotonin transporter during major depressive disorder and antidepressant treatment", J Psychiatry Neurosci, 32, pp.86~102 (2007)
24. DASB PET imaging study, "Am J Psychiatry", 2001, 1843~1849
25. DASB and positron emission tomography, "Biol Psychiatry", 2006, 207~217
26. Sullivan GM, "Positron emission tomography quantification of serotonin-1A receptor binding in medicationfree bipolar depression", Biol Psychiatry, 66, pp.223~230 (2009)
27. Chou YH, "Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study", Bipolar Disord, 12, pp.312~318 (2010)
28. Freitas-Ferrari MC, "Neuroimaging in social anxiety disorder: a systematic review of the literature", Prog Neuropsychopharmacol Biol Psychiatry, 34, pp.565~580 (2010)
29. Maron E, "SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder", Eur Arch Psychiatry Clin Neurosci, 254, pp.392~396 (2004)
30. Lanzenberger RR, "Reduced serotonin-1A receptor binding in social anxiety disorder", Biol Psychiatry, 61, pp.1081~1089 (2007)
31. van der Wee NJ, "Increased serotonin and dopamine transporter binding in psychotropic medicationnaive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT", J Nucl Med, 49, pp.757~763 (2008)
32. Hesse S, "Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder", Psychiatry Res, 140, pp.63~72 (2005)
33. Perani D, "In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessivecompulsive disorder", Neuroimage, 42, pp.306~314 (2008)
34. Kent JM, "Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652", Psychopharmacology (Berl), 164, pp.341~348 (2002)
35. Iqbal N, "The role of serotonin in schizophrenia", Eur Neuropsychopharmacol, 5(Suppl), pp.11~23 (1995)
36. Kapur S, "Serotonin-dopamine interaction and its relevance to schizophrenia", Am J Psychiatry, 153, pp.466~476 (1996)
37. Trichard C, "No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET", Schizophr Res, 31, pp.13~17 (1998)
38. setoperone in neuroleptic-naive patients and normal subjects, "Am J Psychiatry", 1999, 72~78
39. WAY 100635, "Psychopharmacology (Berl)", 2006, 155~164
40. DASB, "Biol Psychiatry", 2005, 1510~1516
41. beta-CIT, "Biol Psychiatry", 2000, 371~379
42. Schmidt LG, "Serotonergic dysfunction in addiction: effects of alcohol, cigarette smoking and heroin on platelet 5-HT content", Psychiatry Res, 72, pp.177~185 (1997)
43. Volkow ND, "Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex", Cereb Cortex, 10, pp.318~325 (2000)
44. Heinz A, "Reduced central serotonin transporters in alcoholism", Am J Psychiatry, 155, pp.1544~1549 (1998)
45. beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers, "Synapse", 2001, 275~284
46. Cosgrove KP, "Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smoking", Neuropsychopharmacology, 34, pp.2218~2226 (2009)
47. β-CIT SPECT imaging study, "Psychiatry Res", 2010, 192~195
48. Yeh TL, "Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study", Psychopharmacology (Berl), 220, pp.55~64 (2012)
49. Lin SH, "The association between availability of serotonin transporters and time to relapse in heroin users: a two-isotope SPECT small sample pilot study", Eur Neuropsychopharmacol, 22, pp.647~650 (2012)
50. Banks ML, "Effects of cocaine and MDMA selfadministration on serotonin transporter availability in monkeys", Neuropsychopharmacology, 33, pp.219~225 (2008)
51. Jacobsen LK, "Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients", Am J Psychiatry, 157, pp.1134~1140 (2000)
52. Oades RD., "Dopamine-serotonin interactions in attentiondeficit hyperactivity disorder (ADHD)", Prog Brain Res, 172, pp.543~565 (2008)
53. Hesse S, "Dopamine transporter imaging in adult patients with attention-deficit", hyperactivity disorder, 2009, pp.171, 120~128
54. Karlsson L, "Serotonin transporter in attention-deficit hyperactivity disorder--preliminary results from a positron emission tomography study", Psychiatry Res, 212, pp.164~165 (2013)
55. Murphy DG, "Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome:an in vivo SPECT study", Am J Psychiatry, 163, pp.934~936 (2006)
56. Makkonen I, "Serotonin and dopamine transporter binding in children with autism determined by SPECT", Dev Med Child Neurol, 50, pp.593~597 (2008)
57. Nakamura K, "Brain serotonin and dopamine transporter bindings in adults with high-functioning autism", Arch Gen Psychiatry, 67, pp.59~68 (2010)
58. Takano A, "Relationship between neuroticism personality trait and serotonin transporter binding", Biol Psychiatry, 62, pp.588~592 (2007)
59. Frokjaer VG, "Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding", Neuropsychopharmacology, 35, pp.1129~1137 (2010)
60. ADAM and SPECT in patients with borderline personality disorder and healthy control subjects, "J Psychiatry Neurosci", 2007, 234~240
61. Huang HY, "Serotonin transporter availability in the midbrain and perceived social support in healthy volunteers", J Psychosom Res, 75, pp.577~581 (2013)
62. Yeh TL, "The relationships between daily life events and the availabilities of serotonin transporters and dopamine transporters in healthy volunteers--a dual-isotope SPECT study", Neuroimage, 45, pp.275~279 (2009)
63. ADAM study, "Eur Neuropsychopharmacol", 2012, 641~646

관련 논문AI추천